US 11773393
Treatment of liver diseases with cell death inducing DFFA like effector B (CIDEB) inhibitors
granted A61KA61K31/7088A61K38/465
Quick answer
US patent 11773393 (Treatment of liver diseases with cell death inducing DFFA like effector B (CIDEB) inhibitors) held by REGENERON PHARMACEUTICALS, INC. expires Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Oct 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K31/7088, A61K38/465, A61P, A61P1/16